Interview of patients by pharmacists contributes significantly to the identification of drug-related problems (DRPs)

Pharmacoepidemiology and Drug Safety

Volumn 15, Issue 9, 2006, Pages 667-674

  Viktil, Kirsten K ^a,c   Blix, Hege Salvesen ^b   Moger, Tron A ^c   Reikvam, Aasmund ^c  

^a DIAKONHJEMMET HOSPITAL   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Clinical significance; Drug related problems (DRPs); Interviewing hospital patients; Type and frequency of DRPs

Indexed keywords

CALCIUM CARBONATE; CELECOXIB; COCODAMOL; DIAZEPAM; LACTULOSE; LANSOPRAZOLE; NAPROXEN; OMEPRAZOLE; SALBUTAMOL; SALMETEROL; SENNA EXTRACT; ZOPICLONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; DRUG USE; FEMALE; GASTROINTESTINAL DISEASE; HOSPITAL PATIENT; HUMAN; INTERMETHOD COMPARISON; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTICENTER STUDY; NORWAY; OBSTRUCTIVE AIRWAY DISEASE; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACEUTICAL CARE; PHARMACIST; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATIC DISEASE; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MEDICATION ERRORS; MIDDLE AGED; NORWAY; PATIENT CARE; PATIENT COMPLIANCE; PHARMACEUTICAL PREPARATIONS; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROFESSIONAL-PATIENT RELATIONS; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 33748803875     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1238     Document Type: Article

References (18)

1. Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of illness model. Arch Intern Med 1995;155(18): 1949-1956.
2. Ernst ME, Iyer S, Doucette WR. Drug-related problems and quality of life in arthritis and low back pain sufferers. Value Health 2003; 6: 51-58.
3. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash) 2001; 41(2): 192-199.
4. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997; 277(4): 301-306.
5. Blix HS, Viktil KK, Reikvam Aa, et al. The majority of patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol 2004; 60(9): 651-658.
6. Andersen SE, Pedersen AB, Bach KF. Medication history on internal medicine wards: assessment of extra information collected from second drug interviews and GP lists. Pharmacoepidemiol Drug Safe 2003; 12: 491-498.
7. Myhr R, Kimsas A. Medication errors when transferring within health care services. Tidsskr Nor Laegeforen 1999; 119: 1087-1091.
8. Frank C, Godwin M, Verma S, et al. What drugs are our frail elderly patients taking? Do drugs they take or fail to take put them in an increased risk of interactions and inappropriate medication use? Can Fam Physician 2001; 47: 1198-1204.
9. Akwagyriam I, Goodyer LI, Harding L, Khakoo S, Millington H. Drug history taking and the identification of drug related problems in an accident and emergency department. J Accic Emerg Med 1996; 13: 166-168.
10. Jones HA, Metz JM, Devine P, Hahn SM, Whittington R. Rates of unconventional medical therapy use in patients with prostata cancer: standard history versus directed questions. Urology 2002; 59: 272-276.
11. Lau HS, Florax C, Porsius AJ, deBoer A. The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards. Br J Clin Pharmacol 2000; 49: 597-603.
12. Oborne CA, Luzac ML. Over-the-counter medicine use prior to and during hospitalisation. Ann Pharmacother 2005; 39: 268-273.
13. WHO Collaborating Centre for Drug Statistics Methodology. 2002. ATC index with DDDs 2002. WHO Collaborating Centre, Oslo.
14. van Mil F. (ed). Proceedings of the International working conference on outcomes measurements in pharmaceutical care. Pharmaceutical Care Network Europe (PCNE): Hilleroed, Denmark, 1999; 9: 84.
15. Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. DICP Ann Pharmacother 1990; 24(11): 1093-1097.
16. Viktil KK, Blix HS, Reikvam Aa, et al. Comparison of drug-related problems in different patient groups. Ann Pharmacother 2004; 38: 942-948.
17. Krska J, Cromarty JA, Arris F, et al. Pharmacist-led medication interview in patients over 65: a randomised, controlled trial in primary care. Age and Aging 2001; 30: 205-211.
18. Jameson JP, VanNoord GR. Pharmacotherapy consultation on polypharmacy patients in ambulatory care. Ann Pharmacother 2001; 35: 835-840.